FDAnews
www.fdanews.com/articles/69696-amt-appoints-new-chief-executive-officer

AMT Appoints New Chief Executive Officer

March 10, 2005

Amsterdam Molecular Therapeutics (AMT) announced the appointment of Ronald Lorijn as chief executive officer. Lorijn replaces Jan Boesen, who left AMT on March 1, 2005.

PharmaLive (http://www.medadnews.com/News/Index.cfm?articleid=219263)